Fibrobiologics Announces Preliminary Proof of Concept for Fibroblast-Based Diabetes Treatment HOUSTON , March 19, 2024 /PRNewswire/ — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”) is focused on developing therapeutics and potential, with …
Tag:
preliminary
-
Type 2
-
Type 1 diabetes is an autoimmune disease in which the body’s immune system attacks and destroys insulin-producing beta cells in the pancreas. Traditional management of his type 1 diabetes has …